Guaifenesin Dm Syrup
NDC Package 60687-817-17
Package Information
Guaifenesin Dm (guaifenesin and dextromethorphan) syrups is follow dosage below or use as directed by a physician.do not take more than 6 doses in any 24-hour period.Age (yr)Dose (mL)adults and children 12 years and over10 mL (2 teaspoonfuls) every 4 hourschildren 6 years to under 12 years5 mL (1 teaspoonful) every 4 hourschildren 2 years to under 6 years2.5 mL (1/2 teaspoonful) every 4 hourschildren under 2 yearsask a doctor. This formulation utilizes a syrup delivery system. Marketed by American Health Packaging, this product is identified by NDC 60687-817 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 60687 - American Health Packaging
- 60687-817 - Guaifenesin Dm
- 60687-817-17 - 10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY (60687-817-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-817-40)
- 60687-817 - Guaifenesin Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60687-817-17 identifies a specific commercial package of 10 tray in 1 case / 10 cup, unit-dose in 1 tray (60687-817-46) / 5 ml in 1 cup, unit-dose (60687-817-40) of Guaifenesin Dm, a human over the counter drug labeled by American Health Packaging. This syrup is formulated for oral use and contains dextromethorphan; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Health Packaging on August 04, 2024. The current certification is valid through December 31, 2026.
How is this American Health Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60687081717. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.